Literature DB >> 20635112

Cognitive deficits in experimental autoimmune encephalomyelitis: neuroinflammation and synaptic degeneration.

G Mandolesi1, G Grasselli, G Musumeci, Diego Centonze.   

Abstract

Multiple sclerosis (MS) is characterized by auto-reactive T cells that respond to central nervous system (CNS)-based antigens and affect motor, sensory as well as behavioral and cognitive functions. Cognitive deficits are now considered an early manifestation of the disease in MS patients. However, the pathophysiology responsible for the cognitive symptoms in MS remains unclear. Increasing evidence from a mouse model of MS, the experimental autoimmune encephalomyelitis (EAE), suggests a correlation between the synaptopathy induced by microglia activation in the early phase of the disease and cognitive dysfunction. In particular, EAE causes deficits in hippocampal-dependent learning and memory that are associated with early microglial activation, synaptic loss and neurodegeneration. Interestingly, inflammatory cytokines released from infiltrating lymphocytes or activated microglia are able to alter synaptic transmission. Increased glutamate-mediated transmission and loss of GABAergic inputs were observed in EAE. They may thus underlie cognitive dysfunction in this model and in MS.

Entities:  

Mesh:

Year:  2010        PMID: 20635112     DOI: 10.1007/s10072-010-0369-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  18 in total

1.  Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.

Authors:  M Donatella Caramia; M Giuseppina Palmieri; M Teresa Desiato; Laura Boffa; Pierluigi Galizia; Paolo M Rossini; Diego Centonze; Giorgio Bernardi
Journal:  Clin Neurophysiol       Date:  2004-04       Impact factor: 3.708

Review 2.  Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia.

Authors:  Luca Muzio; Gianvito Martino; Roberto Furlan
Journal:  J Neuroimmunol       Date:  2007-10-22       Impact factor: 3.478

3.  Glutamate excitotoxicity in a model of multiple sclerosis.

Authors:  D Pitt; P Werner; C S Raine
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

4.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

Authors:  Marina O Ziehn; Andrea A Avedisian; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2010-02-15       Impact factor: 5.662

5.  Improved reversal learning and working memory and enhanced reactivity to novelty in mice with enhanced GABAergic innervation in the dentate gyrus.

Authors:  Fabio Morellini; Elena Sivukhina; Luminita Stoenica; Elena Oulianova; Olena Bukalo; Igor Jakovcevski; Alexander Dityatev; Andrey Irintchev; Melitta Schachner
Journal:  Cereb Cortex       Date:  2010-03-01       Impact factor: 5.357

6.  Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis.

Authors:  Diego Centonze; Luca Muzio; Silvia Rossi; Francesca Cavasinni; Valentina De Chiara; Alessandra Bergami; Alessandra Musella; Marcello D'Amelio; Virve Cavallucci; Alessandro Martorana; Andrea Bergamaschi; Maria Teresa Cencioni; Adamo Diamantini; Erica Butti; Giancarlo Comi; Giorgio Bernardi; Francesco Cecconi; Luca Battistini; Roberto Furlan; Gianvito Martino
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 7.  The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis.

Authors:  D Centonze; L Muzio; S Rossi; R Furlan; G Bernardi; G Martino
Journal:  Cell Death Differ       Date:  2009-11-20       Impact factor: 15.828

8.  APOE 4 polymorphism results in early cognitive deficits in an EAE model.

Authors:  Jiang-long Tu; Chong-bo Zhao; Timothy Vollmer; Stephen Coons; Hao-jie Lin; Stephen Marsh; David M Treiman; Jiong Shi
Journal:  Biochem Biophys Res Commun       Date:  2009-05-05       Impact factor: 3.575

9.  APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.

Authors:  J Shi; C B Zhao; T L Vollmer; T M Tyry; S M Kuniyoshi
Journal:  Neurology       Date:  2007-04-25       Impact factor: 9.910

10.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

View more
  38 in total

Review 1.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

2.  The neuroinflammatory response in humans after traumatic brain injury.

Authors:  C Smith; S M Gentleman; P D Leclercq; L S Murray; W S T Griffin; D I Graham; J A R Nicoll
Journal:  Neuropathol Appl Neurobiol       Date:  2013-10       Impact factor: 8.090

Review 3.  The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS.

Authors:  Dorothy P Schafer; Emily K Lehrman; Beth Stevens
Journal:  Glia       Date:  2012-07-24       Impact factor: 7.452

4.  Targeting synaptic pathology in multiple sclerosis: fingolimod to the rescue?

Authors:  Thomas H Gillingwater
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Selective vulnerability of synaptic signaling and metabolism to nitrosative stress.

Authors:  Alexander A Mongin; Preeti Dohare; David Jourd'heuil
Journal:  Antioxid Redox Signal       Date:  2012-04-18       Impact factor: 8.401

6.  Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.

Authors:  Patrizia LoPresti
Journal:  Neurochem Res       Date:  2014-12-07       Impact factor: 3.996

Review 7.  Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.

Authors:  Robert Nisticò; Francesco Mori; Marco Feligioni; Ferdinando Nicoletti; Diego Centonze
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

8.  Glutamate release machinery is altered in the frontal cortex of rats with experimental autoimmune encephalomyelitis.

Authors:  Natalí L Chanaday; A Alejandro Vilcaes; Ana L de Paul; Alicia I Torres; Alicia L Degano; German A Roth
Journal:  Mol Neurobiol       Date:  2014-07-19       Impact factor: 5.590

9.  Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis.

Authors:  Francesco Mori; Robert Nisticò; Georgia Mandolesi; Sonia Piccinin; Dalila Mango; Hajime Kusayanagi; Nicola Berretta; Alessandra Bergami; Antonietta Gentile; Alessandra Musella; Carolina G Nicoletti; Ferdinando Nicoletti; Fabio Buttari; Nicola B Mercuri; Gianvito Martino; Roberto Furlan; Diego Centonze
Journal:  Neuromolecular Med       Date:  2013-07-28       Impact factor: 3.843

10.  Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients.

Authors:  Pietro Iaffaldano; Rosa Gemma Viterbo; Maria Trojano
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.